Aller au contenu principal
Retour à l'annuaire
RhumatologueMédecins généralistes et spécialistes🏥 Libéral temps partiel hosp.

M. Docteur JULIEN COHEN-SOLAL

📍 Paris (75)Mixte💶 Secteur 2RPPS 10003989604
📊 Reconnaissance scientifique : 1/100📝 3 articles publiés

✨ Profil synthétique

IA · 06/05/2026

Le Dr Julien Cohen-Solal est un rhumatologue exerçant à Paris, avec des recherches publiées sur des sujets variés incluant les infections streptococciques, les systèmes de santé et des pathologies comme le lupus et la maladie de Sjögren. Son activité de recherche est documentée par 3 publications, reflétant un h-index de 1 selon OpenAlex.

Expertises présumées

  • Lupus
  • Maladie de Sjögren
  • Rhumatologie pédiatrique
  • Infections streptococciques
  • Bactériologie médicale
  • Systèmes de santé
  • Pathologies auto-immunes

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • DES Rhumatologie
  • Rhumatologie (SM)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Activité de recherche & publications

Source : bases de données publiques (OpenAlex, PubMed).

h-index

1

h articles cités ≥ h fois chacun. Un h de 1 = 1 publications avec 1+ citations.

Citations

20

Publications

3

i10-index

1

Thématiques principales

  • Streptococcal Infections and Treatments ×2
  • Bacterial Identification and Susceptibility Testing ×2
  • Diphtheria, Corynebacterium, and Tetanus ×2
  • Healthcare Systems and Practices ×1

Affiliations FR : Hôpital Paris Saint-Joseph

Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.

Localisation des cabinets

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

Tarifs & secteur de conventionnement

🟡 Secteur 2 — Honoraires libresSource CNAM (Annuaire santé Ameli)
💳 Carte VitaleLibéral temps partiel hosp.

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Articles de presse (1)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

  • Julien Cohen-Solal, pédiatre connu du grand public par ses livres - Le Monde.fr

    📰 Le Monde.fr · 16/04/2013

    <a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxQcDhLWktfUUJkc1EtZ0NEcFZxZEd2bmVHZTdicE9QTTFsY05YQklmcVV2allmNUY4WC1kTVFNa0Qwb216SWxEeHFoTlIwVUxJSDZVSWliMnRpSjlNaTF6NDRMbmdodGdvcTY2OXlnemhGYmprYXNteGMzcGZudFVZLWxFMHIweW5UdWdUNDNRdWhxNml6UXZ3UTgyMGdZdXdIemdLVGFUaDRYeDJKWGw4clBIbmJmLVUwdn

Top publications · les plus citées

  • 1
    In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response

    Arthritis and rheumatism · 2003

    📚 142 citations🎯 RCR 3.30Top 14% NIH
    Lire l'abstract Crossref ↓

    AbstractObjectiveTo reevaluate, in a large series of patients with Sjögren's syndrome (SS) recruited from 2 French centers, the question of whether HLA is associated with SS itself or with a pattern of secretion of autoantibodies.MethodsOne hundred forty‐nine white patients fulfilling the American‐European Consensus Group criteria for SS were divided into 3 subgroups, according to their anti‐Ro/SSA and anti‐La/SSB status, as follows: group 1 (n = 53), no antibody; group 2 (n = 46), anti‐SSA only; group 3 (n = 50), both anti‐SSA and anti‐SSB. Patients were compared with 222 unrelated healthy subjects representative of the white population in France.ResultsComparisons between the 149 SS patients and 222 controls confirmed the association of SS with DRB1*03 (the frequency was 25% in patients versus 10% in controls) and DQB1*02 (32% versus 22%). The association between HLA and SS was restricted to patients with anti‐SSA and/or anti‐SSB; no association with HLA was observed in patients in group 1 (no antibody). The frequency of HLA–DRB1*15 was highest in group 2 (24%), compared with 11% in group 1 and 11% in controls, whereas the frequency of HLA–DRB1*03 was highest in group 3 (44%), compared with 12% in group 1, 19% in group 2, and 10% in controls. Group 2 and group 3 had more clinical and biologic markers of activity than did group 1 but were not clinically different. HLA alleles were not associated with clinical features of the disease, and were associated with only some biologic features: rheumatoid factor positivity, increased serum IgG, and thrombocytopenia were associated with HLA–DRB1*03, and neutropenia was associated with DQB1*01.ConclusionHLA class II markers confer genetic susceptibility to Sjögren's syndrome. The association between HLA and SS is restricted to patients with anti‐SSA and/or anti‐SSB antibodies; HLA is not associated with SS in patients without these autoantibodies. The absence of a difference in disease severity between groups 2 and 3, as well as the restricted association of HLA–DRB1*03 in group 3, strongly suggest that HLA alleles predispose to autoantibody secretion, without being associated with clinical outcome. HLA class II phenotype might support epitope spreading: HLA–DR15 favors anti‐SSA synthesis, whereas HLA–DR3 is associated with both anti‐SSA and anti‐SSB production.

  • 2
    Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome

    Annals of the rheumatic diseases · 2005

    📚 122 citations🎯 RCR 3.97Top 11% NIH🔓 Open Access📄 PDF gratuit ↗
  • 3
    Sex hormones and SLE: influencing the fate of autoreactive B cells

    Current topics in microbiology and immunology · 2006

    📚 77 citations🎯 RCR 1.71

Publications scientifiques (19) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal10

Sjögren5

Lupus3

Pédiatrie1

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.